APA (7th ed.) Citation

Tsuchiya, K., Yoshimura, K., Inoue, Y., Iwashita, Y., Yamada, H., Kawase, A., . . . Sugimura, H. (2021). YTHDF1 and YTHDF2 are associated with better patient survival and an inflamed tumor-immune microenvironment in non-small-cell lung cancer. OncoImmunology, 10(1), 1. https://doi.org/10.1080/2162402X.2021.1962656

Chicago Style (17th ed.) Citation

Tsuchiya, Kazuo, et al. "YTHDF1 and YTHDF2 Are Associated with Better Patient Survival and an Inflamed Tumor-immune Microenvironment in Non-small-cell Lung Cancer." OncoImmunology 10, no. 1 (2021): 1. https://doi.org/10.1080/2162402X.2021.1962656.

MLA (9th ed.) Citation

Tsuchiya, Kazuo, et al. "YTHDF1 and YTHDF2 Are Associated with Better Patient Survival and an Inflamed Tumor-immune Microenvironment in Non-small-cell Lung Cancer." OncoImmunology, vol. 10, no. 1, 2021, p. 1, https://doi.org/10.1080/2162402X.2021.1962656.